| Name | Title | Contact Details |
|---|
VisuWell is the leader in patient-centered, innovative, and affordable virtual care solutions. The VisuWell platform is an easy-to-use, enterprise-ready, browser-deployed technology increasing healthcare access for health systems, ambulatory care organizations, and payors. VisuWell offers patients and providers a comprehensive telehealth experience for consults, triage, telemedicine visits, and remote patient monitoring over a wide variety of use cases and environments. VisuWell enables care organizations to utilize their own provider networks to offer easy-to-access, high-quality care. The VisuWell platform creates a tailored virtual experience accommodating 35+ use cases serving thousands of locations and helping millions of people to see healthcare differently.
Senomyx is using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients. These include modifiers of Sweet and Salt flavors as well as Savory Flavors, Bitter Blockers, and Cooling Agents. The Company is also engaged in an effort to discover and develop natural high-potency sweeteners. Under its direct sales program, Senomyx is beginning to sell certain of its Complimyx brand flavor ingredients, Sweetmyx, Savorymyx, and Bittermyx, to flavor companies for re-sale to their food and beverage company customers. In addition, Senomyx has collaborative agreements with global food, beverage, and ingredient supply companies, some of which are currently marketing products that contain Senomyx's flavor ingredients.
VISTA HealthPlan is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Maven is the largest virtual clinic for women`s and family health, offering continuous, holistic care for fertility, pregnancy, and parenting. Maven`s award-winning digital programs are trusted by leading employers and health plans to reduce costs and drive better health outcomes for both parents and children. Founded in 2014 by CEO Kate Ryder, Maven has been recognized as Fast Company`s #1 Most Innovative Health Company and has supported more than 10 million women and families to date. Maven has raised $92 million in funding from leading investors including Sequoia, Oak HC/FT, and Female Founders Fund.
Phil is a B2B2C platform that connects patients, pharmacies, prescribers, and manufacturers in the specialty prescription ecosystem. We build software solutions & end-to-end services to power the $320B industry.